Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Comprehensive tumour genomic and transcriptomic analyses Meeting Abstract
| Authors: | Ravaud, A.; Martini, J. F.; Ching, K.; Staehler, M.; Magheli, A.; Escudier, B.; Mu, X. J.; Valota, O.; Lin, X.; Motzer, R. J. |
| Abstract Title: | Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Comprehensive tumour genomic and transcriptomic analyses |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz249.005 |
| Language: | English |
| ACCESSION: | WOS:000491295502333 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz249.005 |
| Notes: | Meeting Abstract: 906PD -- Appears on pages v358-v359 of the abstract book -- Source: Wos |
